Company: NUTR
Filing Date: 2025-03-21
Form Type: S-1
Source: 0001641172-25-000122
Chunk: 176

Company: NUSATRIP Inc
Filing Date: 2025-03-21
Form: S-1
Chunk 176
---
 has been identified as the Chief Financial Officer (“CODM”), who reviews the operating results for the Company
as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that
the Company only has one reportable segment.

When evaluating the Company’s
performance and making key decisions regarding resource allocation, the CODM reviews general and administrative expenses which are included
in the accompanying statements of operations to manage, maintain and enforce all contractual agreements to ensure costs are aligned with
all agreements and budget.

NOTE 16 — COMMITMENTS AND CONTINGENCIES

There is not any obligation or liability including contingent obligation or liability, to the extent that it is not fully reflected in the financial statements.

NOTE 17 — SUBSEQUENT EVENTS

In accordance with ASC Topic 855, “ Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events or transactions that occurred after December 31, 2024, up through March 18, 2025, the Company issued the carve-out combined and consolidated financial statements.

On October 18, 2024, we entered into
a securities purchase agreement with the Selling Stockholders. Pursuant to securities purchase agreement, on October 18, 2024, we issued
convertible notes (the “Convertible Notes”) to the Selling Stockholders with an aggregate principal amount of $1,600,002
(the “Convertible Notes Offering”). Pursuant to the amendments to the securities purchase agreement for Convertible Notes
dated November 13, 2024, entered by the Company and the investors, the Convertible Notes shall automatically convert into shares of our
common stock upon the effectiveness of the registration statement at the conversion price of $1.50 per share. We are obligated to pay
interest to the Selling Stockholders on the outstanding principal amount at the rate of 6.0% per annum. The Convertible Notes and the
interests shall be converted into shares of common stock of the Company at a conversion price of $1.50 per share by the six months anniversary
of the issuance date or the consummation of our IPO, whichever earlier. The Convertible Notes were converted into an aggregate of 1,066,668 shares of Common Stock and
issued to the investors, and
the three private placements were completed on February 10, 2025.

| F-27 |

<div align='center'>NUSATRIP